No Data
No Data
WuXi AppTec Sells Cell, Gene Therapy Unit
Selling ATU's USA and United Kingdom Business, the strategy behind WUXI APPTEC.
There is gain in loss.
WUXI APPTEC will transfer the WuXi ATU Business to a USA Fund. Is the "optimal solution" for the "gray rhino" of the Biological Safety Act?
① This evening, WUXI APPTEC announced that it will transfer its WuXi ATU Business in the USA and United Kingdom to the USA Private Equity Fund Altaris in exchange for Cash.; ② In the first three quarters, WuXi ATU achieved revenue of 0.853 billion, accounting for only about 3% of the total revenue for the first three quarters.; ③ After the transfer of this Business, the accusations and suspicions related to its gene business may be cleared under the Biosecurity Act.
WuXi AppTec Sells Therapy Units to Altaris LLC
Express News | WuXi AppTec - Units to Sell All of Shares in Wuxi Advanced Therapies Inc. to Altaris LLC
Express News | WuXi AppTec - Business Update in Connection With Wuxi Atu Business